TrialMolecular therapy : the journal of the American Society of Gene Therapy2019

A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Hepatocyte Growth Factor in the Treatment of Critical Limb Ischemia.

Yongquan Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.